| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |